Måndag 6 April | 21:00:03 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-11-05 07:30 Kvartalsrapport 2026-Q3
2026-07-17 07:30 Kvartalsrapport 2026-Q2
2026-05-27 N/A X-dag ordinarie utdelning APOTEA 0.60 SEK
2026-05-26 N/A Årsstämma
2026-04-29 07:30 Kvartalsrapport 2026-Q1
2026-02-04 - Bokslutskommuniké 2025
2025-11-06 - Kvartalsrapport 2025-Q3
2025-07-18 - Kvartalsrapport 2025-Q2
2025-05-30 - X-dag ordinarie utdelning APOTEA 0.00 SEK
2025-05-28 - Årsstämma
2025-05-08 - Kvartalsrapport 2025-Q1
2025-02-06 - Bokslutskommuniké 2024

Beskrivning

LandSverige
ListaMid Cap Stockholm
SektorHandel & varor
IndustriDetaljhandel
Apotea är verksamt inom e-handelssektorn och driver ett nätapotek. Bolaget säljer och levererar ett brett utbud av receptbelagda och receptfria läkemedel, hud- och hårvårdsprodukter samt smink och diverse skönhetsrelaterade produkter. Bolaget är verksamt på den svenska hemmamarknaden, där kundbasen huvudsakligen består av privatpersoner. Apotea grundades år 2003 och har sitt huvudkontor i Stockholm.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-03-31 15:00:00

Ahead of the annual general meeting of Apotea AB (publ) (“Apotea”) on May 26, 2026, the Nomination Committee hereby announces its proposal regarding the Chairman of the Board and other members of the Board.

The Nomination Committee proposes that Cecilia Qvist, Anders Eriksson, Monica Lindstedt, Per Schlingmann and Pär Svärdson are re-elected as members of the Board of Directors and that Eva Nilsagård and Johan Lundgren are elected as new members of the Board of Directors of Apotea. Furthermore, the Nomination Committee proposes re-election of Cecilia Qvist as Chairman of the Board. Joanna Hummel left the board on February 4, 2026, to take up an operational role in Apotea. Jonas Hagströmer has informed the Nomination Committee that he declines re-election. The Nomination Committee's proposal means that the number of Board members will remain at seven.

Eva Nilsagård (born 1964) has over 30 years’ experience in senior roles within finance and business development, ranging from large international groups to smaller, entrepreneur-led companies. She has extensive experience of major organisational changes and several initial public offerings, including listings on the Nasdaq Main Market, and currently serves on a number of boards, where she chairs the audit committee.

Johan Lundgren (born 1983) has worked at H&M on several occasions since 2008 and has held roles in sales, business development and operations, both globally and locally. Following a period as Chief Operating Officer at Fortnox, he returned to H&M in 2024, where he is currently responsible for strategy and innovation in his role as Chief Strategy and Innovation Officer.

All of the Nomination Committee's proposals will be presented in the notice to the Annual General Meeting and the proposals and the reasoned statement for the proposed composition of the Board of Directors will also be available on the company's website at the same time.

The Nomination Committee for the 2026 Annual General Meeting consists of Camilla Günesli appointed by Laulima AB, Chair of the Nomination Committee, Karin Cederbaum appointed by Alecta Tjänstepension Ömsesidigt, Björn Henriksson appointed by Nordea fonder, Christopher Beaven appointed by WCM Investment Management, and Cecilia Qvist, Chair of the Board.